Bortezomib
Takeda
['lymphoma']
the long-term results of the remodl-b #clinicaltrial were presented by at the #ash2022 conference today.
the trial has identified subgroups of aggressive #lymphoma where survival is improved by a targeted #cancer drug.
read more 
Southampton Clinical Trials Unit is a CRUK CRC registered CTU with expertise in the design, conduct and analysis of multicentre interventional clinical trials